Headshot photo of Kamalika Roy, M.D., M.C.R.

Kamalika Roy, M.D., M.C.R.

  • Associate Professor of Psychiatry, School of Medicine
  • Program Director, Consultation-Liaison Psychiatry Fellowship
  • OHSU Knight Cancer Institute, School of Medicine

Biography

Dr. Roy is a psycho-oncologist and a passionate advocate for women and underrepresented physicians in organized medicine. She is board certified in Psychiatry and Consultation-Liaison Psychiatry.Currently, she is a faculty in the Department of Psychiatry and Behavioral Sciences at OHSU. She is an attending at the Unity Center for Behavioral Health and at Knight Cancer Institute.

Dr. Roy has served as a Faculty Senator at Oregon Health & Science University. She also served as the faculty liaison to the Diversity, Equity and Inclusion Subcommittee reporting to the Undergraduate Medical Education Committee at OHSU.

Dr. Roy has been actively involved in organized medicine since her residency training. She is a Fellow of APA. She served as a delegate to the International Medical Graduate (IMG) Section of the American Medical Association (AMA). She also chaired the AMA IMG Section. She also serves as a voting member of the Academic Physicians Section at the AMA. She is the Chair of the Awards and Fellowship Subcommittee of the Academy of Consultation-Liaison Psychiatry (ACLP). She also presides over the APA Women's Caucus. As an advocate of IMGs, Dr. Roy has authored and propagated several resolutions facilitating IMG physicians. Dr. Roy published about the IMG physician workforce in a leading journal, shedding light on the interface of healthcare and immigration legislation. She is currently investigating the effect of implicit and explicit biases on IMGs in a national sample. Dr. Roy's passion is to advocate for legislation related to the healthcare workforce, scope of practice, and inclusion of underrepresented and minoritized physicians.

Dr. Roy received her Master's in Clinical Research at OHSU Human Investigations Program.  She currently serves as a board member of the Academy of Physicians in Clinical Research, and a member of the Sigma Xi Professional Scholars Association, Willamette-Columbia Chapter.
 

Education and training

  • Degrees

    • M.B.B.S., 2004, North Bengal Medical College
    • M.A., 2020, Oregon Health & Science University
  • Residency

    • MD, Wayne State University, Detroit, Michigan, 2016
  • Fellowship

    • Consultation-liaison Psychiatry, University of Michigan, Ann Arbor, Michigan, 2017
  • Certifications

    • American Board of Psychiatry and Neurology, 2016
    • American Board of Psychiatry and Neurology, Consultation-Liaison Psychiatry, 2017
    • ECT

Memberships and associations:

  • Washington State Medical Association Academy of Physicians in Clinical Research
  • American Medical Association American Psychiatric Association Academy of Consultation-Liaison Psychiatry Oregon Psychiatric Physicians Association

Areas of interest

  • Psycho-oncology
  • Palliative Psychiatry
  • Sleep Disorders
  • Catatonia
  • Delirium

Honors and awards

  • Early Career Research Mentee Award, Academy of Consultation Liaison Psychiatry (2020)
  • Fellow Award, Academy of Physicians in Clinical Research 2021
  • Fellow of American Psychiatric Association (2019)
  • Distinguished Award for Excellence in Medical Student Education, Oregon Health& Science University (2018)
  • Trainee Travel Award, Academy of Consultation-liaison Psychiatry (2015)
  • Research Award, American Psychiatric Association (2014)

Publications

Elsevier pure profile

Selected publications

  • Sinha A, Smolik TJ, Roy K, Bollu PC. Neuropsychiatric Manifestations of Autoimmune Encephalitis in a Tertiary Hospital: A Case Series and Current Perspectives. J Clin Psychiatry. 2022 Feb 15;83
  • Wilson J.E., Andrews P., Ainsworth A., Roy K., Ely E.W. and Oldham M.A., 2021. Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium. The Journal of Neuropsychiatry and Clinical Neurosciences, pp.appi-neuropsych
  • Roy K, Balon R, Penumetcha V. Persistent Psychosis in Treated Neurosyphilis: When is it Time to Stop Medication? Current psychiatry, 2016 August;15(8):50-52,57-59
  • Roy K., Solenkova, N. & Mehta, P. A Wasted Opportunity During a Pandemic: The Foreign Medical Graduates in the USA. J Immigrant Minority Health 2021. https://doi.org/10.1007/s10903-021-01243-2
  • Shad MU, Felzien E, Roy K, Sethi S. How to identify and manage non-response to clozapine? Asian J Psychiatr. 2019; 45:50-52
  • Roy K, Warnick SJ, R Balon. Catatonia-delirium: Three cases treated with memantine. Psychosomatics 2016; 57(6): 645-650
  • Roy K, Balon R, Penumetcha V, Levine BH. Psychosis and Seizure Disorder: Challenges in Diagnosis and Treatment, Current Psychiatry Reports 2014; 16(11):50
  • Roy K, Balon R, Penumetcha V. Persistent Psychosis in Treated Neurosyphilis: When is it Time to Stop Medication? Current psychiatry, 2016 August;15(8):50-52,57-59

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}